文献速递肿瘤 PET/CT放射性药物与辐射防护

PET血管活动度评分与大动脉炎血管造影进展的关联

Association of PET vascular activity score with Takayasu's arteritis angiographic progression.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-05-28

基于前瞻性观察队列的123例大动脉炎患者,基线PETVAS>15是血管造影进展的独立预测因子(HR 1.93;95%CI 1.01-3.68;p=0.04),但特定动脉区域的FDG摄取与血管进展无关。

要点

  • 基线PETVAS>15是大动脉炎血管造影进展的独立预测因子(HR 1.93;95%CI 1.01-3.68;p=0.04)。
  • 特定动脉区域的基线FDG摄取与血管进展无相关性。
  • 基线PETVAS与ESR、血清IL-6及血小板呈正相关。

核心结论

  • 基线PETVAS>15是大动脉炎血管造影进展的独立预测因子。
  • 特定动脉区域的基线FDG摄取与血管进展无相关性。
  • 本研究为大动脉炎血管进展提供了可行的PET/CT预测标志物,并强调定期影像随访监测疾病结局的重要性。

研究设计与样本

  • 前瞻性观察队列研究,纳入基线接受18F-FDG PET/CT及血清学检测的大动脉炎患者。
  • 基线和随访期间每6个月进行磁共振血管造影和/或超声造影检查。
  • 影像评估包括123例患者的1353个动脉区域。

主要发现

  • 随访30(18-72)个月期间,45例患者(36.6%)出现血管造影进展,涉及72个动脉区域(5.3%)。
  • 45例进展患者中19例(42.2%)基线PETVAS>15,其中84.2%(16/19)为初治病例,78.9%(15/19)ESR≥30 mm/h。
  • 基线PETVAS与ESR、血清IL-6及血小板呈正相关。
  • 多因素Cox回归校正年龄和性别后,基线PETVAS>15为血管造影进展的独立预测因子(HR 1.93;95%CI 1.01-3.68;p=0.04)。

临床怎么用

  • 作者认为基线PETVAS>15可作为大动脉炎血管进展的可行PET/CT预测标志物。
  • 作者强调定期影像随访监测疾病结局的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Arterial wall Fluorodeoxyglucose (FDG) uptake can reflect vascular inflammation in Takayasu's arteritis (TAK); however, its association with vascular prognosis remains unclear. This study assessed the predictive efficacy of the PET vascular activity score (PETVAS) for vascular prognosis and whether FDG uptake in specific arterial territories was associated with angiographic progression in TAK. METHODS: Patients with TAK from a prospective observational cohort who underwent 18F-FDG PET/CT and serological tests at baseline were included. Magnetic Resonance Angiography and/or Contrast-Enhanced Ultrasound were conducted at baseline and every six months during follow-up. The PETVAS was calculated. New/aggravated lesions were considered as angiographic progression. RESULTS: The imaging evaluation included 1,353 arterial territories from 123 patients. The baseline PETVAS was positively correlated with Erythrocyte Sedimentation Rate (ESR), serum IL-6, and Platelet. Angiographic progression was noted in 45 patients (36.6%) with 72 territories (5.3%) during 30 (18-72) months of follow-up. Of these, 19 (42.2%) had baseline PETVAS > 15, including 84.2% (16/19) naïve cases and 78.9% (15/19) with ESR ≥ 30 mm/h. Multivariate Cox proportional hazards regression analysis adjusted for age and sex showed baseline PETVAS > 15 (HR 1.93; 95% CI, 1.01-3.68; p = 0.04) an independent predictor of angiographic progression. CONCLUSION: Baseline PETVAS > 15 was an independent predictor of angiographic progression in TAK. Baseline FDG uptake in specific arterial territories did not correlate with vascular progression. Our study provides a feasible PET/CT-based predictive marker for vascular progression in TAK and underscores the importance of regular imaging follow-up to monitor disease outcomes. CLINICAL TRIAL NUMBER: Not applicable.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Wu S, Wu B, Ma L, et al. Association of PET vascular activity score with Takayasu's arteritis angiographic progression. Eur J Nucl Med Mol Imaging. 2025. PMID: 40434493. doi:10.1007/s00259-025-07348-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。